title: Intravesical therapies for bladder cancer - indications and limitations.
abstract: • Intravesical therapy is a well-established treatment option for non-muscle-invasive bladder cancer (NMIBC). • Choosing the appropriate intravesical agent, schedule and duration of treatment has long been an area of debate. • We review the intravesical agents that are currently used in the management of NMIBC and examine the indications and limitations of their use. • Given the relative high rates of toxicity, failure and non-completion of traditional treatments we also examine some of the newer treatment options available.
authors.affiliation: School of Surgery, University of Western Australia, Fremantle, Western Australia, Australia.
authors.forename: Callum
authors.initials: C
authors.lastname: Logan
authors.forename: Matthew
authors.initials: M
authors.lastname: Brown
authors.forename: Dickon
authors.initials: D
authors.lastname: Hayne
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents